Hengrui Medicine_Providing professional financial news and data related to Hengrui Medicine, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Hengrui Medicine (01276.HK): SHR-6914 Injection Approved for Clinical Trials

Tags：

Hengrui Medicine 01276.HK

2026-06-16

Finance
Yum China (09987.HK): Plans to Acquire Ownership of Pizza Hut Brand in Chinese Mainland for USD1.2 Billion
Finance
Hengrui Medicine (01276.HK): SHR-6914 Injection Approved for Clinical Trials
Finance
Da Hang Technology Industry (02543.HK): Ye Ka Mei Resigns as Joint Company Secretary and Board Secretary
Finance
Shun Yuen Enterprise Group (01748.HK): Appointment of Tang Xuming as Executive Director
Finance
Hong Shing Cheong Resources (01850.HK): Supplementary Disclosure of Curriculum Vitae for Newly Appointed Independent Non-executive Director Huang Zhenguo
Finance
Hong Kong Credit Corporation (01273.HK): Profit Attributable to Shareholders Expected to Rise 40%–60% Year-on-Year
Finance
MINIEYE Innovation (02431.HK): Signs Procurement Deal for 1,000 Autonomous Logistics Vehicles and Long-Term Cooperation Agreement
Finance
Baixin International (00574.HK): Ma Qinghai Resigns as Executive Director and Chief Executive Officer
Finance
Regent Pacific Group (00575.HK): Senstend™ Approved for Marketing by National Medical Products Administration
Finance
Dongjiang Environment (00895.HK): Fulfils Guarantee Obligation of Approximately RMB1.1983 Million for Controlled Subsidiary Mianyang Dongjiang

Scan QR Code

Download App